Norinchukin Bank’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-125,159
| Closed | -$12.4M | – | 518 |
|
|
2019
Q3 | $12.4M | Buy |
125,159
+3,236
| +3% | +$307K | 0.18% | 92 |
|
|
2019
Q2 | $11.3M | Sell |
121,923
-49,008
| -29% | -$4.65M | 0.17% | 87 |
|
|
2019
Q1 | $16.1M | Buy |
170,931
+5,477
| +3% | +$479K | 0.21% | 91 |
|
|
2018
Q4 | $10.6M | Buy |
165,454
+39,497
| +31% | +$2.92M | 0.15% | 109 |
|
|
2018
Q3 | $11.3M | Buy |
125,957
+10,093
| +9% | +$892K | 0.15% | 102 |
|
|
2018
Q2 | $9.2M | Buy |
115,864
+8,723
| +8% | +$724K | 0.14% | 103 |
|
|
2018
Q1 | $9.56M | Sell |
107,141
-37,220
| -26% | -$3.57M | 0.16% | 95 |
|
|
2017
Q4 | $15.1M | Buy |
144,361
+4,921
| +4% | +$555K | 0.26% | 64 |
|
|
2017
Q3 | $20.3M | Buy |
139,440
+19,082
| +16% | +$2.6M | 0.39% | 41 |
|
|
2017
Q2 | $15.6M | Buy |
120,358
+29,957
| +33% | +$3.67M | 0.32% | 47 |
|
|
2017
Q1 | $11.2M | Buy |
90,401
+4,024
| +5% | +$482K | 0.24% | 67 |
|
|
2016
Q4 | $10M | Buy |
86,377
+5,755
| +7% | +$641K | 0.23% | 66 |
|
|
2016
Q3 | $8.43M | Buy |
80,622
+781
| +1% | +$84.5K | 0.2% | 73 |
|
|
2016
Q2 | $7.88M | Buy |
79,841
+336
| +0.4% | +$34.8K | 0.19% | 75 |
|
|
2016
Q1 | $7.96M | Buy |
79,505
+3,119
| +4% | +$321K | 0.19% | 77 |
|
|
2015
Q4 | $9.15M | Sell |
76,386
-8,530
| -10% | -$987K | 0.23% | 69 |
|
|
2015
Q3 | $9.19M | Buy |
84,916
+230
| +0.3% | +$28.5K | 0.24% | 66 |
|
|
2015
Q2 | $9.8M | Sell |
84,686
-2,771
| -3% | -$317K | 0.25% | 60 |
|
|
2015
Q1 | $10.1M | Buy |
87,457
+29,754
| +52% | +$3.56M | 0.24% | 59 |
|
|
2014
Q4 | $6.46M | Buy |
57,703
+23,184
| +67% | +$2.45M | 0.16% | 89 |
|
|
2014
Q3 | $3.27M | Buy |
34,519
+4,635
| +16% | +$418K | 0.09% | 103 |
|
|
2014
Q2 | $2.57M | Sell |
29,884
-3,718
| -11% | -$283K | 0.08% | 107 |
|
|
2014
Q1 | $2.35M | Buy |
33,602
+2,818
| +9% | +$223K | 0.07% | 117 |
|
|
2013
Q4 | $2.6M | Sell |
30,784
-110
| -0.4% | -$8.7K | 0.07% | 104 |
|
|
2013
Q3 | $2.38M | Buy |
30,894
+2,000
| +7% | +$140K | 0.07% | 100 |
|
|
2013
Q2 | $1.69M | Buy |
+28,894
| New | +$1.74M | 0.05% | 120 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Norinchukin Bank's CELG Position: Q4 2019 in Review
Norinchukin Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 125,159 shares — an estimated $12.4M sold.
Norinchukin Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $20.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Norinchukin Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Norinchukin Bank sold 125,159 Celgene Corp shares in Q4 2019, an estimated $12.4M.
- Norinchukin Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Norinchukin Bank's Celgene Corp position peaked at $20.3M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Norinchukin Bank's 13F filing for Q4 2019, filed 12 Feb 2020.